- The efficacy of combined treatment with recombinant human tumor necrosis factor-alpha and 5-fluorouracil is dependent on the development of capillaries in tumor. Manda, T., Nishigaki, F., Mukumoto, S., Masuda, K., Nakamura, T., Shimomura, K. Eur. J. Cancer (1990)